1935
DOI: 10.1007/bf02145185
|View full text |Cite
|
Sign up to set email alerts
|

Zur pathologischen Anatomie der Thorakoplastik

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

1941
1941
2018
2018

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…The aim of the procedure is to reduce the size of the chest wall to eliminate a hollow space, or to compress a pathologically altered lung. [1][2][3][4] This surgical method (also called collapse therapy of chest wall) historically applied to treat cavernous forms of lung tuberculosis and to eliminate empyematous cavities. 3,5 Gradually, the technique of thoracoplasty has been significantly modified 6 and currently it is complemented frequently by a myoplasty such as thoracomyoplasty.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The aim of the procedure is to reduce the size of the chest wall to eliminate a hollow space, or to compress a pathologically altered lung. [1][2][3][4] This surgical method (also called collapse therapy of chest wall) historically applied to treat cavernous forms of lung tuberculosis and to eliminate empyematous cavities. 3,5 Gradually, the technique of thoracoplasty has been significantly modified 6 and currently it is complemented frequently by a myoplasty such as thoracomyoplasty.…”
Section: Introductionmentioning
confidence: 99%
“…7 Thoracoplasty was initiated in the late 19th century to treat destructive lung tuberculosis and was also a "last chance" treatment for chronic pleural empyema (in various intra/extrapleural modifications with different degrees of mutilation). 1,4,6,8 The need for surgical intervention was considerably reduced as a result of the introduction of effective drug therapy of tuberculosis (starting with Streptomycin in 1944, then PAS, INH, and most recently Rifampicin, in 1966) as well as the development of multimodal and targeted treatment of pleural empyema.…”
Section: Introductionmentioning
confidence: 99%